More Middle East Pharmaceutical Industries Company news
Middle East Pharmaceutical Industries CompanyTADAWUL: 4016

Avalon Pharma H2 Dividend Per Share SAR 1.32

Mar 8, 2026 at 9:16 AM EDT · Issued by Middle East Pharmaceutical Industries Company

On 6ix: 6ix.com/news/avalon-pharma-h2-dividend-per-share-sar-1.32

MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:

  • AVALON PHARMA H2 DIVIDEND PER SHARE SAR 1.32

Middle East Pharmaceutical Industries Company on 6ix

Story so far

  • Middle East Pharmaceutical Industries H2 Dividend Per Share SAR 1.25Apr 13, 2025

Earlier from Middle East Pharmaceutical Industries

  • Avalon Pharma FY Profit 97.01 Mln RiyalsMar 4
  • Avalon Pharma Contract Sign Off With Bio-Thera SolutionsFeb 4
  • Avalon Pharma Grants Three Bonus Shares For Every Four Shares HeldFeb 1
  • Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta SasNov 26, 2025
  • Avalon Pharma Q3 Profit SAR 8.28 MlnNov 5, 2025

Later from Middle East Pharmaceutical Industries

  • Avalon Pharma Appoints Ahmad Shaher Al Tabbaa As ChairmanApr 16
  • Avalon Pharma Q1 Profit SAR 26.9 MillionMay 6
All Middle East Pharmaceutical Industries news releases↗

Follow Middle East Pharmaceutical Industries into a list and get an email when it puts out news.

Follow Middle East Pharmaceutical Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer